Devyser achieves breakthrough in the US with cystic fibrosis NGS test
Devyser has secured a CFTR NGS proposal with UNC Hospitals. The proposal with UNC Hospitals is...
As part of our registration process, we need some information from you to process your orders smoothly. We need your shipping and billing details to ensure that your orders are accurately processed and delivered on time.
11660 Alpharetta Highway
Suite 700, Office 790
Roswell, Georgia 30076
United States
News | Feb 29, 2024
Devyser announces study publication demonstrating dd-cfDNA detection in dual donor kidney transplant patientNews | Feb 20, 2024
Devyser Diagnostics AB publishes year-end report for January to December 2023News | Feb 06, 2024
Devyser strengthens its management teamDevyser has secured a CFTR NGS proposal with UNC Hospitals. The proposal with UNC Hospitals is...
Read More
Devyser Diagnostics AB announces today an article titled “Detection of donor-derived cell-free DNA...
Read More
“Devyser is able to report strong sales growth and record high gross margins for the fourth...
Read More
Read More